IMMUNOLOGICAL PROPERTIES OF SYNTHETIC HUMAN PARATHYROID HORMONE 53–84 FRAGMENT

1979 ◽  
Vol 80 (1) ◽  
pp. 153-155 ◽  
Author(s):  
G. N. HENDY ◽  
R. M. MANNING ◽  
M. ROSENBLATT ◽  
G. W. TREGEAR ◽  
H. T. KEUTMANN ◽  
...  

The immunological properties of a synthetic peptide comprising the carboxyl-terminal 53–84 region of human parathyroid hormone (PTH) have been studied. The immunoreactivity of the synthetic human PTH-(53–84) peptide paralleled that of a 53–84 fragment of the native human hormone prepared by enzymic digestion, in both a standard radioimmunoassay, which was not region-specific, and also a radioimmunoassay specific for the carboxyl-terminal region of PTH. However, in both types of radioimmunoassay the synthetic human PTH-(53–84) peptide was four to five times more reactive than the native human PTH-(53–84) fragment.

1974 ◽  
Vol 47 (6) ◽  
pp. 567-576 ◽  
Author(s):  
G. N. Hendy ◽  
P. M. Barling ◽  
J. L. H. O'Riordan

1. Immunological assay systems specific to the amino-terminal region of parathyroid hormone were used to study the properties of human parathyroid hormone (HPTH 1-84) and of synthetic peptides. One of these peptides (HPTH 1-34A) had the sequence proposed by Niall, Sauer, Jacobs, Keutmann, Segre, O'Riordan, Aurbach & Potts (1974). The others (HPTH 1-34B and C, synthesized by different methods) had the sequence proposed by Brewer, Fairwell, Ronan, Sizemore & Arnaud (1972). 2. HPTH 1-84 and HPTH 1-34A behaved identically in a number of these systems. In some systems, especially those using antisera obtained by immunizing with HPTH 1-34A, differences were, however, found. These may be due to conformational or other physical differences or to the presence of an immunologically incomplete site in the fragment. 3. In systems in which HPTH 1–84 and HPTH 1-34A behaved identically the peptides with the sequence proposed by Brewer et al. (1972) were of low reactivity by 100–2000-fold.


Endocrinology ◽  
1978 ◽  
Vol 103 (3) ◽  
pp. 978-984 ◽  
Author(s):  
MICHAEL ROSENBLATT ◽  
GINO V. SEGRE ◽  
GEOFFREY W. TREGEAR ◽  
GARY L. SHEPARD ◽  
GEORGE A. TYLER ◽  
...  

2021 ◽  
Vol 572 ◽  
pp. 15-19
Author(s):  
Kittrawee Kritmetapak ◽  
Ravinder J. Singh ◽  
Theodore A. Craig ◽  
Jolaine M. Hines ◽  
Rajiv Kumar

Endocrinology ◽  
2005 ◽  
Vol 146 (4) ◽  
pp. 1863-1870 ◽  
Author(s):  
P. Divieti ◽  
A. I. Geller ◽  
G. Suliman ◽  
H. Jüppner ◽  
F. R. Bringhurst

1978 ◽  
Vol 24 (3) ◽  
pp. 451-454 ◽  
Author(s):  
F P Di Bella ◽  
J M Kehrwald ◽  
K Laakso ◽  
L Zitzner

Abstract Antisera directed toward the carboxyl-terminal region of human parathyrin (parathyroid hormone), for use in daignostically applicable radioimmunoassays of the hormone in serum, are scarce, largely because of the lack of suitable immunogens of human origin. We produced four antisera in goats and guinea pigs by immunization with recently discovered carboxyl-terminal fragments of human parathyrin extracted from parathyroid tumors. Here, we report results of radioimmunoassays of nearly 200 normal and pathological sera with one of these antisera; we observed almost complete differentiation between concentrations of parathyrin in serum of healthy normal subjects and patients with primary, secondary (due to chronic renal failure), or "ectopic" hyperparathyroidism (due to nonparathyroid cancer). The availability of a new immunogen should now make possible the deliberate production of large quantities of diagnostically applicable parathyrin antisera directed toward the carboxyl-terminal region of human parathyrin. This should, in turn, lead to more widespread availability of this useful radioimmunoassay.


1980 ◽  
Vol 199 (1) ◽  
pp. 286-296 ◽  
Author(s):  
Michael Rosenblatt ◽  
Geoffrey W. Tregear ◽  
Gary L. Shepard ◽  
George A. Tyler ◽  
Marta Veroni ◽  
...  

Endocrinology ◽  
1995 ◽  
Vol 136 (11) ◽  
pp. 4732-4740 ◽  
Author(s):  
N Inomata ◽  
M Akiyama ◽  
N Kubota ◽  
H Jüppner

1981 ◽  
Vol 53 (1) ◽  
pp. 76-84 ◽  
Author(s):  
STEPHEN J. MARX ◽  
MARK E. SHARP ◽  
ADRIAN KRUDY ◽  
MICHAEL ROSENBLATT ◽  
LAWRENCE MALLETTE

1980 ◽  
Vol 85 (1) ◽  
pp. 161-170 ◽  
Author(s):  
R. M. MANNING ◽  
G. N. HENDY ◽  
S. E. PAPAPOULOS ◽  
J. L. H. O'RIORDAN

SUMMARY Antisera to a trichloroacetic-acid precipitate of human parathyroid hormone (PTH) were produced in goats. Two of these antisera (G36 and G31) were of high affinity, and the bovine and porcine hormones were less reactive. Synthetic peptides containing the amino-terminal region of human PTH reacted with both antisera; the 1–34 peptide (PTH-(1–34)), with the sequence proposed by Niall, Sauer, Jacobs, Keutmann, Segre, O'Riordan, Aurbach & Potts in 1974, was more reactive than that having the sequence proposed by Brewer, Fairwell, Ronan, Sizemore & Arnaud in 1972. The antisera were further characterized with a number of other native and synthetic fragments of human PTH and reacted poorly with fragments from the carboxy-terminal region of the molecule. Since the amino-terminal fragments did not account for all the immunoreactivity, it is assumed that the antisera had some recognition sites for the central part of the molecule. Highly purified human PTH-(1–84) was labelled with 125I and radioimmunoassays were developed using this tracer and antiserum G36. To avoid the problems associated with labelling human PTH with 125I, a labelled antibody assay was developed with G36 and an immunoadsorbent consisting of human PTH-(1–34) (sequence of Niall et al.) coupled to cellulose. A sensitive homologous amino-terminal specific assay was developed in this way.


Sign in / Sign up

Export Citation Format

Share Document